| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Feinberg Peter serves as a Director at IMRX. Across recent SEC filings that breaks down to 16 buys and 0 sells. Those positions are worth an estimated $589K at current prices.
Historically, Feinberg Peter's trades have earned a below-average insider score of 43/100 across 12 rated trades. Over a 12-month horizon, 14.3% of those trades were profitable, with an average 12-month return of -34.8%.
The biggest single holding is IMRX (~$589K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 474,183 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 | IMRX Immuneering Corp | Director | Buy | 291,667 | $15.00 | $4,375,005.00 | -165.5% | +40.0% | -64.3% |